title: Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study.
abstract: This cohort retrospective study explored the cost and clinical consequences of smoking cessation in outpatients after cardiovascular events (CVEs), in Spain. A total of 2,540 patients (68.1 years; 60.7% male; 8.4% smokers, 52.9% ex-smokers, and 38.7% never smokers) fulfilling the selection criteria and followed up throughout a period of 36 months after the event were considered eligible for analysis. Total costs were higher among current smokers in comparison with ex-smokers and never smokers (€7,981 versus [vs] €7,322 and €5,619, respectively) (P < 0.001). Both health care costs (€6,273 vs €5,673 and €4,823, respectively) (P < 001) and loss of productivity at work costs (€1,708 vs €1,650 and €796, respectively) (P < 001) accounted for such differences. There was also a difference in CVE recurrence rates (18.6% vs 16.5% and 9.6%, respectively) (P < 01). Smoking cessation in CVE outpatients was associated with lower cost and risk of CVE recurrence compared with smokers, and their health status was similar to that of never smokers, in routine clinical practice in Spain.
authors: Directorate of Planning, Badalona Serveis Assistencials SA, Badalona, Spain.
authors: Antoni
authors: A
authors: Sicras-Mainar
authors: Silvia
authors: S
authors: Díaz-Cerezo
authors: Verónica Sanz
authors: VS
authors: de Burgoa
authors: Ruth
authors: R
authors: Navarro-Artieda
keywords: health care costs; health resources; mortality
references: Rev Esp Cardiol. 2008 Jun;61(6):620-8
references: 18570783
references: BMC Cardiovasc Disord. 2009 May 27;9:21
references: 19473535
references: Nicotine Tob Res. 2001 Aug;3(3):249-55
references: 11506768
references: Eur Heart J. 1999 Mar;20(5):344-53
references: 10206381
references: Gac Sanit. 2002 Jul-Aug;16(4):308-17
references: 12106550
references: Int J Cardiol. 2009 Oct 2;137(2):171-4
references: 18687488
references: Med Clin (Barc). 2009 Sep 5;133(8):290-5
references: 19596366
references: Med Clin (Barc). 2005 May 28;124(20):769-71
references: 15927102
references: Arch Bronconeumol. 2003 Jan;39(1):35-41
references: 12550018
references: Lancet. 2006 Aug 19;368(9536):647-58
references: 16920470
references: Ann Cardiol Angeiol (Paris). 2012 Apr;61(2):105-10
references: 21872211
references: J Hypertens Suppl. 1990 Sep;8(5):S3-8
references: 2286855
references: Neurol Neurochir Pol. 2010 Mar-Apr;44(2):181-7
references: 20496288
references: Lancet. 2004 Sep 11-17;364(9438):937-52
references: 15364185
references: Am J Med. 1992 Jul 15;93(1A):8S-12S
references: 1497005
references: Prog Cardiovasc Dis. 2003 Jul-Aug;46(1):11-29
references: 12920698
references: Rev Esp Cardiol. 2002 Apr;55(4):337-46
references: 11975899
references: Circulation. 2010 Feb 16;121(6):750-8
references: 20124123
references: Prog Cardiovasc Dis. 2003 Mar-Apr;45(5):383-94
references: 12704595
references: BMJ. 2000 Apr 29;320(7243):1197-200
references: 10784550
references: BMJ. 2009 Aug 18;339:b3060
references: 19690343
references: Med Care. 1991 May;29(5):452-72
references: 1902278
references: Eur Heart J. 1999 Dec;20(24):1773-82
references: 10581135
references: J Chronic Dis. 1987;40(5):373-83
references: 3558716
references: Arch Bronconeumol. 2007 Dec;43(12):669-73
references: 18053544
references: Eur J Cardiovasc Prev Rehabil. 2004 Apr;11(2):101-12
references: 15187813
references: JAMA. 1998 Oct 28;280(16):1405-9
references: 9800999
references: Arch Intern Med. 2012 Jun 11;172(11):837-44
references: 22688992
references: J Vasc Surg. 2002 Mar;35(3):506-9
references: 11877699